Single Oral Toxicity of (R)-JG-381 in Sprague-Dawley Rats
![]() |
이상호
(한국화학연구원 안전성연구센터)
오우용 (한국화학연구원 안전성연구센터) 김종춘 (한국화학연구원 안전성연구센터) 주상섭 (서울대학교 약학대학) 박형근 (서울대학교 약학대학) 함광수 ((주)태평양제약 중앙연구소) 조장섭 ((주)태평양제약 중앙연구소) 이선미 (성균관대학교 약학대학) |
1 | Collier, G. R., Traianedes, K., Macaulay, S. L. and O'Dea, K-(1993). Effect of fatty acid oxidation inhibition on glucose metabolism in diabetic rats. Horm. Metab. Res. 25, 9-12 DOI ScienceOn |
2 | Ho, W., Tutwiler, G. F., Cottrell, S. C., Morgans, D. J., Tarhan, 0. and Mohrbacher, R. J. (1986). AIkylglycidic acids: potential new hypoglycemic agents. J. Med. Chem. 29, 2184-2190 DOI |
3 | Martin, C., Odeon, M., Cohen, R. and Beylot, M. (1991). Mecha-nisms of the glucose lowering effect of a camiline palmitoyl transferase inhibitor in normal and diabetic rats. Metabolism. 40, 420-427 DOI ScienceOn |
4 | Agius, L., Mercdith, E. J. and Sherratt, H. S. (1991). Stereo-specificity of the inhibition by etomoxir of fatty acid and cholesterol synthesis in isolated rat hepatocytes. Biochem. Pharmacol. 9, 1717-1720 |
5 | Wolf, H. P. (1992). Possible new therapeutic approach in diabetes mellitus by inhibition of carnitine Paimitoyltrans-ferase 1 (CPTl). Horm. Metab. Res. SuppI. 26, 62-67 |
6 | Oh, W. Y., Lee, S. H., Kim, H. J., Jew, S. S., Park, H. G., Ham, K. S., Cho, J. S. and Lee, S. M. (2001). Single oral toxicity of JG-381 in rats. J Appl. Pharmacol. 9, 231-235 |
7 | Ratheiser, K.., Schneeweiss, B., Waldhausl, W., Fasching, P., Korn, A., Nowotny, P., Rohac, M. and Wolf, H. P. (1991). Inhibition by ctomoxir of camitine palmitoyltransferase I reduces hepatic glucose production and plasma lipids in non-insulin-dependent diabetes mellitus. Metabolism. 40, 1185-1190 DOI ScienceOn |
8 | Turcani, M. and RupP, H. (1999). Modification of left Ventri-cular hypertrophy by chronic etomixir treatment. Br. J. Pharmacol. 126, 501-507 |
9 | 식품의악품안전청(1999). 의약품등의 독성시힘기준, 식품의약품안전청고시 제1999-61호 |
10 | 식품의악품안전청(2000). 비임상시험 관리기준, 식품의약품안전청고시 제2000-63호 |
![]() |